Holen Sie sich die Stockscreener-App
12.70
6.11%
-0.875
Schlusskurs vom Vortag:
$13.57
Offen:
$13.41
24-Stunden-Volumen:
858.06K
Relative Volume:
1.06
Marktkapitalisierung:
$1.15B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-56.88M
KGV:
-19.23
EPS:
-0.6604
Netto-Cashflow:
$-39.43M
1W Leistung:
+1.31%
1M Leistung:
+36.31%
6M Leistung:
+116.02%
1J Leistung:
+287.39%
1-Tages-Spanne:
$12.25
$13.43
1-Wochen-Bereich:
$12.25
$14.11
52-Wochen-Spanne:
$2.87
$14.11
Alpha Tau Medical Ltd Stock (DRTS) Company Profile
Firmenname
Alpha Tau Medical Ltd
Sektor
Branche
Telefon
-
Adresse
-
Compare DRTS vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DRTS
Alpha Tau Medical Ltd
|
12.74 | 1.20B | 0 | -56.88M | -39.43M | -0.6604 |
VRTX
Vertex Pharmaceuticals Inc
|
524.31 | 134.02B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
672.45 | 68.59B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
921.42 | 58.44B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
320.25 | 41.76B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
191.68 | 40.23B | 742.00K | -1.37B | -1.07B | -7.0731 |
Alpha Tau Medical Ltd Stock (DRTS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-04 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-12-15 | Eingeleitet | Citigroup | Buy |
| 2023-04-24 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-04-14 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-04-08 | Eingeleitet | Piper Sandler | Overweight |
| 2022-04-04 | Eingeleitet | Citigroup | Buy |
Alle ansehen
Alpha Tau Medical Ltd Aktie (DRTS) Neueste Nachrichten
Alpha Tau Medical: Alpha Particles Are Still Interesting, But Beware The Hype (NASDAQ:DRTS) - Seeking Alpha
Alpha Tau Medical (DRTS) CFO trades 2,270 shares in exercise and sale - Stock Titan
Enterprise value to revenue forward of Alpha Tau Medical Ltd. – NASDAQ:DRTS - TradingView
Price to sales forward of Alpha Tau Medical Ltd. – BOATS:DRTS - TradingView
Insider Sell: Raphi Levy Sells Shares of Alpha Tau Medical Ltd (DRTS) - GuruFocus
Alpha Tau Medical (DRTS) Is Up 17.9% After First International Alpha DaRT Glioblastoma Procedure – Has The Bull Case Changed? - simplywall.st
Alpha Tau Medical (DRTS) notice: 20,000 shares from option exercise to be sold - Stock Titan
Alpha Tau Medical (DRTS) CFO exercises 17,873 options and sells 17,873 shares - Stock Titan
Alpha Tau Medical (DRTS) price target increased by 15.15% to 9.69 - MSN
Alpha Tau Medical (NASDAQ: DRTS) CFO sells 2,127 shares after exercising options - Stock Titan
Form 144 Alpha Tau Medical Ltd. For: 2 July By Investing.com - Investing.com Canada
Levy Raphi to sell 20,000 Alpha Tau shares (DRTS) via Form 144 - Stock Titan
Alpha Tau Medical Ltd. Warrant 2022-07.03.27 on Alpha Tau Med Rg-A Financial Disclosures & SEC Filings - TradingView
DRTS Stock Price, Quote & Chart - ChartMill
Insider Sell: Raphi Levy Sells 20,000 Shares of Alpha Tau Medica - GuruFocus
Alpha Tau Medical (DRTS) CFO sells 20,000 shares, retains 90,180 - Stock Titan
Alpha Tau Medical stock hits 52-week high at $11.64 By Investing.com - Investing.com South Africa
Alpha Tau Medical stock hits 52-week high at $11.64 - Investing.com UK
Form 144 Alpha Tau Medical Ltd. For: 30 June By Investing.com - Investing.com South Africa
Insider sells 37,500 shares at Alpha Tau Medical (NASDAQ: DRTS) - Stock Titan
H.C. Wainwright Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Maintains Target Price $15 - Moomoo
Why Alpha Tau Medical (DRTS) Is Up 11.2% After First Alpha DaRT Brain-Tumor Procedure News - Sahm
Alpha Tau Medical’s (DRTS) First International Brain Cancer Use Tests The Breadth Of Its Alpha DaRT Platform - Yahoo Finance
Form 144 Alpha Tau Medical Ltd. For: 26 June By Investing.com - Investing.com South Africa
Alpha Tau Medical (DRTS) CFO sells 20,000 Ordinary Shares - Stock Titan
Raphi Levy sale: 17,500 shares disclosed for Alpha Tau Medical (DRTS) - Stock Titan
Alpha Tau Medical (DRTS) Looks Fully Priced After Its Glioblastoma Treatment Milestone - simplywall.st
Alpha Tau Medical (NASDAQ: DRTS) shareholders back board, pay and auditor at AGM - Stock Titan
Alpha Tau Medical Ltd Actuals & Estimates (NASDAQ:DRTS) - TradingView
Insider Sell Alert: Raphi Levy Sells Shares of Alpha Tau Medical Ltd (DRTS) - GuruFocus
DRTS Forecast — Price Target — Prediction for 2027 - TradingView
Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan Repayment, Strategic Portfolio Appreciation, and a Strengthened Balance Sheet - PR Newswire
Alpha Tau Medical (DRTS) CFO reports open-market sale of 17,500 shares - Stock Titan
Alpha Tau Medical Ltd (DRTSW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
symbol__ Stock Quote Price and Forecast - CNN
Alpha Tau Medical Ltd (DRTSW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Form 6K Alpha Tau Medical Ltd For: 23 June By Investing.com - Investing.com India
Alpha Tau Treats First Recurrent Glioblastoma Patient Outside U.S. With Alpha DaRT in Israel - TipRanks
Alpha Tau Medical (Nasdaq: DRTS) treats first recurrent glioblastoma patient outside U.S. - Stock Titan
Form 144 Alpha Tau Medical Ltd. For: 23 June By Investing.com - Investing.com Australia
Alpha Tau first treats glioblastoma patient outside the U.S. in Israel - Stock Titan
Alpha Tau Medical (DRTS) Form 144: Director plans sale of 17,500 shares on Nasdaq - Stock Titan
Finanzdaten der Alpha Tau Medical Ltd-Aktie (DRTS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Alpha Tau Medical Ltd-Aktie (DRTS) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Levy Raphi | Chief Financial Officer |
Jul 06 '26 |
Sale |
14.00 |
2,270 |
31,782 |
90,180 |
2.18%
2.70%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):